Experimental strategy of animal trial for the approval of anti-diabetic agents prior to their use in pre-human clinical trials
References
Aley KO, Levine JD. Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain. 2001; 2: 146-50.
CCAC. Guide to the care and used of experimental animals. Vol. 1. The Canadian Council on Animal Care, 1993.
Courteix C, Eschalier A, Lavarenne J. Streptozotocin-induced diabetic rats: Behavioral evidence for a model of chronic pain. Pain 1993; 53: 81-88.
Cunha JM, Funez MI, Cunha FQ, Parada CA, Ferreira SH. Streptozotocin induced mechanical hypernociception is not dependent on hyperglycemia. Braz J Med Biol Res. 2009; 42: 197-206.
Frode TS, Medeiros YS. Animal models to test drugs with potential anti-diabetic activity. J Ethnopharmacol.2008; 115: 173-183.
Shukla S, Mehta P, Bajpai VK. Evaluation of comparative anti-diabetic effects of ethanolic extracts of Caesalpinia bouncucella and Stevia rebaudiana in normal and alloxan-induced experimental rats. Rom Biotechnol Lett. 2011; 16: 6187-99.
Soumyanath A. Traditional medicines for modern times: Anti-diabetic plants. London, CRC Press, 2006.
Turner MA. Screening methods in pharmacology. New York, Academic Press, 1965, p 26.
Apply citation style format of Bangladesh Journal of Pharmacology
Copyright (c) 2016 Vivek K. Bajpai, Irfan A. Rather, Gyeong-Jun Nam
This work is licensed under a Creative Commons Attribution 4.0 International License.
